Right to Try Act
Have you been able to access drugs in clinical trials using the Right to Try Act? If so, could you please share what the process was like?
Below are some websites and phone numbers for additional information. Please post any and all informational websites and phone numbers.
Key FDA Contact Information
For specific questions on:
- Investigational Drugs: CDER’s Division of Drug Information – 301-796-3400 or [email protected]
- Investigational Biologics: CBER’s Office of Communication, Outreach and Development – 240-402-8020 or 800-835-4709 or [email protected]
For general questions, or if you are unsure of whom to contact, contact the Patient Affairs Staff – 301-796-8460 or [email protected].
FDA is available to answer questions regarding the Right to Try Act. Patients with specific Right To Try requests should consult their physician.
Log in to reply.